Skip to main content
. Author manuscript; available in PMC: 2013 May 20.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2013 Jan 17;33(3):474–480. doi: 10.1161/ATVBAHA.112.301078

Figure 4.

Figure 4

Human apolipoprotein (apo) A-V immunoblot. Recombinant human apoA-V was separated by SDS-PAGE, transferred to a polyvinylidene difluoride membrane, and probed with plasma collected from AAV2/8-LacZ mice (Lane 1) and AAV2/8-apoA-V (Lane 2) mice, 8 weeks after infection.